Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2005-03-01
2005-03-01
Hartley, Michael G. (Department: 1616)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
Reexamination Certificate
active
06861044
ABSTRACT:
The present invention concerns the use of a radioiodinated phenolic compound of the formulawherein: m and n are independently 0, 1, 2 or 3, X is a group that is negatively or positively charged at physiological pH, R, R1, R2and R3are independently hydrogen, C1-C4alkyl, or a carboxyl group, and I* is123I,131I or125I, and its pharmaceutically-acceptable salts. The compound is formulated and used in vivo in an animal in brachytherapy in an implantable catheter. In addition, due to the rapid renal clearance of these compounds, they may be used to study renal function. A process to prepare these compounds is also disclosed.
REFERENCES:
patent: 4574079 (1986-03-01), Gavras et al.
patent: 5163896 (1992-11-01), Suthanthiran
patent: 5393512 (1995-02-01), Vanderheyden
patent: 5429582 (1995-07-01), Williams
patent: 5611767 (1997-03-01), Williams
patent: DT-139918 (1975-04-01), None
patent: 9855154 (1998-12-01), None
Wahl, R.; Bohner, J.; Kallee. E. Nucl. Med. Suppl. (1973), No. 11, p. 179-83 (German plus translation).
Wahl, R.; Bohner, Jurgen; et al. Arzneim.-Forsch (1973), 23(8), p. 1009-14 (German plus translation).
De Wit. Peter; Woldhuis, Alex F.; Cerfontain, Hans; Lab. Org. Chem. U of Amsterdam; Racl. Trav. Chim. Pays-Bas 107, 668-675 (1988).
Phillip, Manfred; Fresenius J. Anal. Chem (1998), 360(2), p. 184-191.
Krummeich C. et al. “Convenient Direct NCA Electrophilic Radioiodination of Arenes using lodo-gene<TM” Applied Radiation and Isotopes, vol. 47, No. 5, May 6, 1996, pp. 489-495.
Krummeich C. et al. “Kit preparation of n.c.a. 3-”[123] lodo-L-α-methyltyrosine [123l]IMT, 3-[123l]lodo-O-methyl-L-tyrosine [123l]OMIT and 3-[123l]lodo-O-methyl-L-α-methyltyrosine [123l]OMIMT Using Sep-Pak™ C-18 Cartridges, appl. Radiar. Isol. vol. 46, No. 9, pp. 917-6921, 1995.
Krummeich C. et al. “Synthesis and Biodistribution of Radioiodinated Amino acids: A Comparative Evaluation” Journal of Nucl. Med. vol. 3, No. 5 Suppl., pp. 94, 1994.
Frank R. Keith
Simon Jaime
Strickland Alan D.
Hartley Michael G.
The Dow Chemical Company
LandOfFree
Radioiodinated sulfonated phenols and process therefore does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioiodinated sulfonated phenols and process therefore, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioiodinated sulfonated phenols and process therefore will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3426877